BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/26/2025 3:57:03 AM | Browse: 19 | Download: 48
 |
Received |
|
2025-08-19 01:32 |
|
Peer-Review Started |
|
2025-08-19 01:32 |
|
First Decision by Editorial Office Director |
|
2025-09-04 07:16 |
|
Return for Revision |
|
2025-09-04 07:16 |
|
Revised |
|
2025-09-17 02:29 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-10-31 02:34 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-10-31 08:19 |
|
Articles in Press |
|
2025-10-31 08:19 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-11-20 02:15 |
|
Publish the Manuscript Online |
|
2025-11-26 03:57 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Role of human umbilical cord mesenchymal stem cells in diabetic kidney disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yan Liu, Xiao-Qian Shan, Yu-Jiao Li, Wei-Li Gao and Lan Zhao |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Lan Zhao, Academic Fellow, /, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, No. 88 Changling Road, Xiqing District, Tianjin 300381, China. lanzhao69@163.com |
| Key Words |
Human umbilical cord mesenchymal stem cells; Diabetes; Diabetic kidney disease; Metabolic dysregulation; Metabolic dysfunction-associated steatotic liver disease; Diabetic complications |
| Core Tip |
This letter to the editor focuses on investigating how human umbilical cord mesenchymal stem cells (hUC-MSCs) contribute to diabetic kidney damage. At the same time, explore the similarities and differences of hUC-MSCs in treating metabolic dysfunction-associated steatotic liver disease and diabetic kidney disease. There are benefits of using hUC-MSCs to treat metabolic disorders. Future studies on the relationship between hUC-MSCs and the management of metabolic disorders ought to be promoted. |
| Publish Date |
2025-11-26 03:57 |
| Citation |
Liu Y, Shan XQ, Li YJ, Gao WL, Zhao L. Role of human umbilical cord mesenchymal stem cells in diabetic kidney disease. World J Stem Cells 2025; 17(11): 113201 |
| URL |
https://www.wjgnet.com/1948-0210/full/v17/i11/113201.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v17.i11.113201 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
